- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/56 - Nitrogen atoms
Patent holdings for IPC class C07D 211/56
Total number of patents in this class: 311
10-year publication summary
|
29
|
23
|
15
|
21
|
15
|
18
|
12
|
14
|
9
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2722 |
21 |
| ChemoCentryx, Inc. | 374 |
8 |
| ADT Pharmaceuticals, LLC | 12 |
8 |
| Cytokinetics, Inc. | 263 |
7 |
| Bristol-myers Squibb Company | 4793 |
6 |
| Sumitomo Chemical Company, Limited | 9064 |
6 |
| Amicus Therapeutics, Inc. | 353 |
6 |
| Araxes Pharma LLC | 92 |
6 |
| Mission Therapeutics Limited | 79 |
6 |
| Janssen Pharmaceutica N.V. | 3298 |
5 |
| Oryzon Genomics S.A. | 106 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 863 |
5 |
| Unichem Laboratories Limited | 96 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2641 |
4 |
| Sanofi | 4164 |
4 |
| Rappta Therapeutics Oy | 9 |
4 |
| Centre National de La Recherche Scientifique | 10830 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 773 |
3 |
| Kaneka Corporation | 4636 |
3 |
| The Trustees of the University of Pennsylvania | 4396 |
3 |
| Other owners | 193 |